Kingworld Medicines Group Limited provided consolidated earnings guidance for the year ended 31 December 2021. The group is expected to record an increase in the profit attributable to owners of the company by approximately 155% to 160% for the Year as compared to the profit attributable to owners of the Company of RMB 11.7 million for the year ended 31 December 2020 (the "Previous Year").
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.57 HKD | +1.79% | -1.72% | -9.52% |
May. 29 | Kingworld Medicines Group Limited Approves Final Dividend for the Year Ended 31 December 2023 | CI |
Apr. 23 | Kingworld Medicines Posts 68% Jump in 2023 Profit | MT |
1st Jan change | Capi. | |
---|---|---|
-9.52% | 43.23M | |
+26.77% | 76.29B | |
-2.27% | 23.99B | |
+10.27% | 9.01B | |
+12.25% | 8.67B | |
-24.34% | 7.58B | |
+12.70% | 5.18B | |
+2.89% | 4.16B | |
-4.96% | 3.98B | |
-1.36% | 3.63B |
- Stock Market
- Equities
- 1110 Stock
- News Kingworld Medicines Group Limited
- Kingworld Medicines Group Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2021